The role of Pvs28 in sporozoite development in Anopheles sinensis and its longevity in BALB/c mice

Experimental Parasitology

Volumn 127, Issue 2, 2011, Pages 346-350

  Kim, Tong Soo ^a,c   Kim, Hyung Hwan ^b,d   Moon, Sung Ung ^c   Lee, Sun Sim ^c   Shin, E Hyun ^c   Oh, Chang Mi ^c   Kang, Yoon Joong ^d,e   Kim, Do Kyung ^d,e   Sohn, Youngjoo ^f   Kim, Hyuck ^e   Lee, Hyeong Woo ^c,g  

^a Inha University School of Medicine   (South Korea)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Korea Centers for Disease Control and Prevention   (South Korea)

^d Jungwon University   (South Korea)

^e International Research Center of Bioscience and Biotechnology   (South Korea)

^f Department of Computer and Electronic Physics   (South Korea)

^g UNIVERSITY OF FLORIDA   (United States)

Author keywords

Longevity; Monoclonal antibody; Ookinete surface protein; Plasmodium vivax; Transmission blocking vaccine

Indexed keywords

IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; PARASITE ANTIGEN; RECOMBINANT OOKINETE SURFACE PROTEIN 28; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANOPHELES; ANOPHELES SINENSIS; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; ESCHERICHIA COLI; EXPRESSION VECTOR; FEMALE; IMMUNE RESPONSE; KOREA; LONGEVITY; MOLECULAR WEIGHT; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; SPOROZOITE; TH1 CELL; TH2 CELL; WESTERN BLOTTING;

ANIMALS; ANOPHELES; ANTIBODIES, MONOCLONAL; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; ANTIGENS, SURFACE; BLOTTING, WESTERN; CLONING, MOLECULAR; CYTOKINES; DNA, PROTOZOAN; FEMALE; HUMANS; INSECT VECTORS; MALARIA VACCINES; MALARIA, VIVAX; MICE; MICE, INBRED BALB C; PLASMODIUM VIVAX; POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS;

ANOPHELES SINENSIS; ESCHERICHIA COLI; MUS; PLASMODIUM VIVAX;

EID: 78751580473     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2010.08.015     Document Type: Article

References (29)

1. Arakawa T., Chong D.K., Langridge W.H. Efficacy of a food plant-based oral cholera toxin B subunit vaccine. Nature Biotechnology 1998, 16:292-297.
2. Barr P.J., Green K.M., Gibson H.L., Bathurst I.C., Quakyi I.A., Kaslow D.C. Recombinant Pfs25 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in experimental animal. Journal of Experimental Medicine 1991, 174:1203-1208.
3. Benedict M.Q. Care and maintenance of anopheline mosquito colonies. The Molecular Biology of Insect Disease Vectors 1997, 3-12. New York, Champman & Hall. J.M. Crampton, C.B. Beard, C. Louis (Eds.).
4. Chai I.H., Lim G.I., Yoon S.N., Oh W.I., Kim S.J. Occurrence of tertian malaria in a male patient who has never been abroad. Korean Journal of Parasitology 1994, 32:195-200.
5. Duffy P.E., Pimenta P., Kaslow D.C. Pgs28 belongs to a family of epidermal growth factor-like antigens that are targets of malaria transmission-blocking antibodies. Journal of Experimental Medicine 1993, 177:505-510.
6. Duffy P.E., Pimenta P., Kaslow D.C. A novel malaria protein, Pfs28, and Pfs25 are genetically linked and synergistic as falciparum malaria transmission-blocking vaccines. Infection and Immunity 1997, 65:1109-1113.
7. Gozar M.M.G., Price V.L., Kaslow D.C. Saccharomyces cerevisiae-secreted fusion proteins Pfs25 and Pfs28 elicit potent Plasmodium falciparum transmission-blocking antibodies in mice. Infection and Immunity 1998, 60:59-64.
8. Grech K., Maung L.A., Read A.F. The effect of parental rearing conditions on offspring life history in Anopheles stephensi. Malaria Journal 2007, 6:130.
9. Harinasuta T., Suntharasamai P., Viravan C. Chloroquine-resistant falciparum malaria in Thailand. Lancet 1965, 2:657-660.
10. Hisaeda H., Stowers A.W., Tsuboi T., Collins W.E., Sattabongkot J.S., Suwanabun N. Antibodies to malaria vaccine candidates Pvs25 and Pvs28 completely block the ability of Plasmodium vivax to infect mosquitoes. Infection and Immunity 2000, 68:6618-6623.
11. Kapturczak M.H., Wasserfall C., Brusko T., Campbell-Thompson M., Ellis T.M., Atkinson M.A., Agarwal A. Heme oxygenase-1 modulates early inflammatory responses evidence from the heme oxygenase-1-deficient mouse. American Journal of Pathology 2004, 165:1045-1053.
12. Kaslow D.C., Quakyi I.A., Syin C., Raum M.G., Keister D.B., Coligan J.E. A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains. Nature 1988, 333:74-76.
13. Khan S.S., Smith M.S., Reda D., Suffredini A.F., McCoy J.P. Multiplex bead array assays for detection of soluble cytokines: comparisons of sensitivity and quantitative values among kits from multiple manufacturers. Cytometry 2004, 61B:35-39.
14. Klein T.A., Pacha L.A., Lee H.C., Kim H.C., Lee W.J., Lee J.K., Jeung G.G., Sames W.J., Gaydos J.C. Plasmodium vivax malaria among U.S. Forces Korea in the Republic of Korea, 1993-2007. Military Medicine 2009, 174:412-418.
15. Lee H.W., Cho S.H., Shin E.H., Lee J.S., Lee J.S., Chai J.Y., Lee S.H., Kim T.S. Experimental infection of Anopheles sinensis with Korean isolates of Plasmodium vivax. Korean Journal of Parasitology 2001, 39:177-183.
16. Lee H.W., Shin E.H., Cho S.H., Lee H.I., Kim C.L., Lee W.G., Moon S.U., Lee J.S., Lee W.J., Kim T.S. Detection of vivax malaria sporozoites naturally infected in Anopheline mosquitoes from endemic areas of northern parts of Gyeonggi-do (Province) in Korea. Korean Journal of Parasitology 2002, 40:75-81.
17. National Malaria Eradication Service, 1966. Malaria pre-eradication program in Korea. Progress report 1961-1965. Ministry of Health and Social Affairs, ROK. pp. 44-70.
18. Paik Y.H., Ree H.I., Shim J.C. Malaria in Korea. The Japanese Journal of Experimental Medicine 1988, 58:55-66.
19. Rieckmann K.H., Davis D.R., Hutton D.C. Plasmodium vivax resistance to chloroquine?. Lancet 1989, 2:1183-1184.
20. Roberts D.R., Andre R.G. Insecticide resistance issues in vector bore disease control. American Journal of Tropical Medicine and Hygiene 1994, 50:21-34.
21. Rosenberg R., Rungsiwongse J. The number of sporozoites produced by individual malaria oocysts. American Journal of Tropical Medicine and Hygiene 1991, 45:574-577.
22. Sattabongkot J., Tsuboi T., Hisaeda H., Tachibana M., Suwanabun N., Rungruang T., Cao Y.M., Stowers A.W., Sirichaisinthop J., Coleman R.E., Torii M. Blocking of transmission to mosquitoes by antibody to Plasmodium vivax malaria vaccine candidates Pvs25 and Pvs28 Despite antigenic polymorphism in field isolates. American Journal of Tropical Medicine and Hygiene 2003, 69:536-541.
23. Soh J.T., Lee K.T., Im K.I., Min D.Y., Ahn M.H., Kim J.J., Yong T.S. Current status of malaria in Korea. Yonsei Report on Tropical Medicine 1985, 16:11-18.
24. Sun J.B., Holmgren J., Czerkinsky C. Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proceedings of the National Academy of Sciences of the United States of America 1994, 91:10795-10799.
25. Tsuboi T., Kaslow D.C., Gozar M.M., Tachibana M., Cao Y.M., Torii M. Sequence polymorphism in two novel Plasmodium vivax ookinete surface proteins, Pvs25 and Pvs28, that are malaria transmission-blocking vaccine candidates. Molecular Medicine 1998, 4:772-782.
26. Tsuboi T., Cao Y.M., Hitsumoto Y., Yanagi T., Kanbara H. Two antigens of zygotes and ookinetes of Plasmodium yoelii and Plasmodium bergei that are distinct targets of transmission-blocking immunity. Infection and Immunity 1997, 65:2260-2264.
27. Yamada M. Four kinds of Anopheline mosquitoes in Chosen. Keijo Journal of Medicine 1936, 7:191-210.
28. Yamada M. A new species of Anopheles in Chosen (Korea). Keijo Journal of Medicine 1937, 8:237-255.
29. Wang L., Kedzierski L., Wesselingh S.L., Coppel R.L. Oral immunization with a recombinant malaria protein induces conformational antibodies and protects mice against lethal malaria. Infection and Immunity 2003, 71:2356-2364.